Emerald Bioscience Stock Working Capital
Emerald Bioscience fundamentals help investors to digest information that contributes to Emerald Bioscience's financial success or failures. It also enables traders to predict the movement of Emerald OTC Stock. The fundamental analysis module provides a way to measure Emerald Bioscience's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Emerald Bioscience otc stock.
Emerald |
Emerald Bioscience OTC Stock Working Capital Analysis
Emerald Bioscience's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Emerald Bioscience Working Capital | (206 K) |
Most of Emerald Bioscience's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emerald Bioscience is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
CompetitionBased on the company's disclosures, Emerald Bioscience has a Working Capital of (206,000). This is 100.05% lower than that of the Healthcare sector and 100.04% lower than that of the Biotechnology industry. The working capital for all United States stocks is 100.01% higher than that of the company.
Emerald Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Emerald Bioscience's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Emerald Bioscience could also be used in its relative valuation, which is a method of valuing Emerald Bioscience by comparing valuation metrics of similar companies.Emerald Bioscience is currently under evaluation in working capital category among related companies.
Emerald Fundamentals
| Return On Equity | -740.91 | |||
| Return On Asset | -224.1 | |||
| Current Valuation | 86.55 M | |||
| Shares Outstanding | 133.91 M | |||
| Shares Owned By Insiders | 59.50 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Earning | (0.62) X | |||
| Price To Book | (9.09) X | |||
| Revenue | 399.91 K | |||
| Gross Profit | 166.22 K | |||
| EBITDA | (4.51 M) | |||
| Net Income | (19.19 M) | |||
| Cash And Equivalents | 1.85 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 1.36 M | |||
| Debt To Equity | (2.11) % | |||
| Current Ratio | 0.12 X | |||
| Book Value Per Share | (0.12) X | |||
| Cash Flow From Operations | (3.94 M) | |||
| Earnings Per Share | (0.16) X | |||
| Beta | -0.04 | |||
| Market Capitalization | 87.04 M | |||
| Total Asset | 692 K | |||
| Retained Earnings | (9.84 M) | |||
| Working Capital | (206 K) | |||
| Current Asset | 635 K | |||
| Current Liabilities | 841 K | |||
| Z Score | -1.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in employment. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Consideration for investing in Emerald OTC Stock
If you are still planning to invest in Emerald Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Emerald Bioscience's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |